《中国长城文献资料数据库》 …… 由长城小站长城志愿者建设

文献标题	评论者	评论内容	评论时间
从居延汉简看汉代随军下层妇女生活贾丽英	[未验证] Floy	�׀��捍ӾԑӺ杭� I am happy with the quality and range ߋf machines avvailable ɑt Optical Bonding Machine. Ƭһе products ѕuch aѕ lcd laminating machine, laminator oca, and lcd bonding machine aге νery effective. Advanced equipment like cof bonding machine, acf bonding machine, and adhesive bonding machine add real νalue. I аlso liked tools like vacuum laminating machine, vacuum laminator, ɑnd glass laminating machine ԝhich help achieve precision. Fߋr display repair, products ѕuch aѕ OCA bonding machine, oca lamination machine, ɑnd oca machine аrｅ extremely helpful. Thhe range ߋf bubble remover machine, lcd bubble removing machine, аnd mini bubble remover machine solve ρroblems effectively. Οverall, tһіѕ site іѕ ᴠery professional fоr anyone looking fοr optical bonding display and air removing machine.	2025-10-01 16:20:48
结构奇巧的“轿子城” 赵俊	[未验证] Shawna	֔俊：�ṹǦȉ�ġ敖ϗӳǡ� The Heart Of The Internet Below is a broad overview of the potential side‑effects associated with 5‑alpha‑reductase inhibitors such as finasteride (commonly used for benign prostatic hyperplasia and androgenic alopecia). The information is meant to help you understand the medical risks, not to guide how or why you should use the drug. --- 1. Common (usually mild) side‑effects Category Typical symptoms Frequency Sexual function Decreased libido, erectile dysfunction, reduced ejaculate volume, decreased penile sensitivity ~1–5 % of users Mood / cognition Mild depression, anxiety, or irritability < 2 % Breast changes Tenderness or swelling of breasts (galactorrhea) < 0.1 % > These effects are usually transient and resolve after stopping the medication. --- 2. Rare but notable adverse events Condition Approximate prevalence Key points Persistent sexual dysfunction ~0.1–0.5 % (lasting > 6 months) May require psychiatric or urologic consultation; consider dose adjustment or switching therapy. Breast cancer risk Slight increase in some meta‑analyses (~1–2 % relative risk over 10 years) Baseline mammography recommended before initiating therapy, then every 2 years. Prostate abnormalities Rare (< 0.05 %) but reported Monitor PSA and digital rectal exam if symptoms develop. --- Practical Recommendations for Your Practice Pre‑prescription Workup - Baseline prostate‑specific antigen (PSA) level, digital rectal exam (DRE), and a brief history of urinary symptoms. - Discuss breast cancer screening: recommend baseline mammogram if not up to date. Patient Education - Explain potential side effects: urinary urgency/irritation, erectile dysfunction, breast tenderness. - Provide contact information for immediate concerns (e.g., sudden urinary retention). Follow‑up Schedule - First visit at 4–6 weeks post‑initiation to assess tolerability and efficacy. - Subsequent visits every 12 weeks or as clinically indicated. Monitoring for Adverse Events - Promptly evaluate any reports of difficulty urinating, pain in breasts, or changes in sexual function. - Adjust dose or discontinue if significant adverse effects occur. Documentation - Record baseline and follow‑up symptom scores (e.g., AUA Symptom Index). - Note medication adherence, side effect profile, and any dosage adjustments. --- 6. Key Take‑away Points for the Resident Item Key Message Why it matters Prostate enlargement causes urinary symptoms; managing these improves quality of life. Treatment hierarchy Lifestyle → Pharmacotherapy (α1-blockers, 5‑ARI) → Combination therapy → Surgery. Combination therapy Effective when monotherapies fail or in moderate to severe BPH with significant LUTS. Drug selection Tamsulosin + Finasteride commonly used; consider patient comorbidities, drug interactions, and side effects. Monitoring PSA trends, symptom score (IPSS), post‑void residual volume, adverse events. Side‑effects Sexual dysfunction is most common; counsel patients and involve them in shared decision‑making. Patient education Importance of medication adherence, lifestyle modifications, and prompt reporting of urinary retention or bleeding. --- 8. Summary & Take‑Home Points BPH leads to lower urinary tract symptoms due to prostate enlargement compressing the urethra. Combination therapy (α1‑blocker + 5‑ARI) offers superior symptom relief and reduces progression compared with monotherapy, especially in men >50 years or with larger prostates. While combination therapy improves efficacy, it carries a higher risk of sexual side effects; thorough counseling is essential. Long‑term data support the benefit of combination therapy for reducing prostate cancer incidence, although evidence is mixed; more research is needed to clarify this aspect. In clinical practice, tailor treatment based on age, prostate size, symptom severity, and patient preference regarding side‑effect profiles. References Matzuk AM, et al. J Urol. 2024;202(3):123–134. Lee YJ, et al. Asian J Androl. 2024;26(1):45–58. Patel R, et al. Clin Exp Urol. 2025;15(4):312–320. (Full citation details available upon request.) References: crazy mass results (Brandi)	2025-10-01 16:11:17
榆林新明楼魏忠贤铜像考徐涛刘合心	[未验证] Antoinette	Ѭ͎ 岛Аģ�Ԝ–тķ�&# Understanding The Anavar Cycle: Duration, Goals, And Results How AI and Machine_Learning Models Can Assist in Parkinson_s Disease (PD) Diagnosis Below is an overview that explains the concepts and approaches researchers and clinicians use to support PD diagnosis with AI. It covers the most common data types, typical machine_learning pipelines, illustrative studies, and practical considerations for real_world deployment. > NOTE _ This guide is informational only. Clinical decisions should always be made by qualified health professionals using validated diagnostic tools and guidelines (e.g., Movement Disorder Society criteria, MDS-UPDRS). --- 1. Why AI Helps Traditional Diagnosis Limitations How AI Adds Value Neurological exam + history + UPDRS Subjective, variable inter_rater reliability Quantifies subtle patterns, reduces observer bias Imaging (MRI/CT) Expensive, limited sensitivity for early disease Detects micro_structural changes via advanced analysis Wearable data (accelerometry) Requires manual feature extraction Learns features directly from raw signals --- 2. Typical Data Sources Modality Common Measures Example Feature Accelerometer (wrist/ankle) Raw tri_axial acceleration, gyroscope RMS velocity amplitude Gyroscope Angular velocity Mean tilt angle Pressure sensor Footfall force Peak pressure distribution Video Pose keypoints (OpenPose) Joint angle trajectories EEG/EMG Raw voltage traces Muscle activation timing --- 3. Feature Engineering Workflow Pre_processing - Resample to a common frequency. - Apply low_pass filter (e.g., 4th order Butterworth) to remove noise. - Remove gravity component via high_pass filtering or sensor fusion. Segmentation - Detect gait events (heel strike, toe off) using thresholding on acceleration magnitude. - Window the data into strides (~0.5_1_s). Feature Extraction Domain Feature Type Example Time_domain Statistical moments mean, std, skewness, kurtosis of each axis Peak detection max/min acceleration peaks per stride Zero_crossing rate number of times signal crosses zero Frequency_domain Spectral energy sum of power spectral density in gait frequency band (0.5_3_Hz) Dominant frequency frequency with maximum PSD Time_frequency Wavelet coefficients detail coefficients at scales corresponding to stride period Implementation Tip: Use `scipy.signal.welch` for PSD estimation; apply a Hamming window to reduce spectral leakage. 4.2 Feature Selection and Dimensionality Reduction With dozens of extracted features, selecting the most informative subset improves classifier performance and reduces overfitting. Correlation Analysis: Compute Pearson correlation coefficients between features and target labels. Remove highly correlated pairs (e.g., correlation > 0.9) to avoid redundancy. Recursive Feature Elimination (RFE): Employ scikit-learn_s `RFE` with a lightweight estimator (e.g., Logistic Regression or Random Forest) to rank features iteratively. Principal Component Analysis (PCA): Reduce dimensionality while preserving variance. PCA components can serve as inputs to the classifier if interpretability is not critical. Illustrative Code Snippet from sklearn.feature_selection import RFE, SelectKBest, f_classif Assuming X_features and y_labels are prepared estimator = RandomForestClassifier(n_estimators=100) selector = RFE(estimator, n_features_to_select=10, step=1).fit(X_features, y_labels) X_selected = selector.transform(X_features) Reduced feature set 3. Classification Model: Support Vector Machine (SVM) 3.1 Algorithmic Overview A Support Vector Machine constructs a hyperplane in the feature space that maximally separates classes. For two_class problems, the optimization seeks to minimize $\|w\|$ subject to correct classification constraints: $ y_i (\langle w, x_i \rangle + b) \ge 1 - \xi_i $, with slack variables $\xi_i \ge 0$ allowing misclassification. Regularization parameter $C$ balances margin width and training error. The dual formulation introduces Lagrange multipliers $\alpha_i$: [ \max_\alpha \sum_i=1^N\alpha_i - \frac12\sum_i,j\alpha_i\alpha_j y_iy_j K(x_i, x_j) ] subject to $0 \le \alpha_i \le C$ and $\sum_i \alpha_i y_i = 0$, where $K$ is the kernel. Training complexity scales with number of support vectors (SVs). In high dimensions, the dot product computation $x_i^\top x_j$ becomes expensive; however, since each vector has at most 10 non-zero entries, sparse matrix operations can be employed to accelerate this step. 3.2 Random Forests Random forests build an ensemble of decision trees on bootstrap samples and random subsets of features at splits. The number of trees $T$, depth, and feature subset size are key hyperparameters. Computational Complexity Training: For each tree, we sample $n_s \approx 0.632 n$ instances (bootstrap). At each node, we evaluate a random subset of features $m_f$ (commonly $\sqrtd$) to find the best split. The cost per split is proportional to $O(m_f \log n_s)$ if sorted splits are used; otherwise, $O(n_s m_f)$. The total cost per tree thus depends on depth $D$: roughly $O(T D m_f n_s)$. Prediction: Each instance traverses one path per tree (depth $D$), checking a single feature at each node. Thus $O(T D)$ operations. In practice, with shallow trees ($D \approx 3-5$) and small number of trees ($T \approx 10-30$), both training and inference are inexpensive. 2.2 Random Forests Random forests extend decision trees by introducing bagging (bootstrap aggregating) and random feature selection at splits: For each tree, sample with replacement $n_s$ instances from the training set. At each node, select a random subset of features (size $m$) and find the best split among them. The key differences in complexity are: Training: The bootstrap sampling adds negligible overhead; the feature subsampling reduces the cost per node because fewer candidate splits must be evaluated. Inference: Each tree still requires traversing from root to leaf, so the cost is similar to that of a single decision tree. However, since we now have many trees, inference scales linearly with the number of trees. Because each tree is shallow and the feature subsampling dramatically reduces the time per node, random forests can be trained quickly even for large numbers of trees. 3.4 Empirical Observations When measuring training times on real datasets (e.g., image classification tasks), we observe: Training Time: Random forest training time scales roughly linearly with the number of trees and logarithmically with the depth of each tree, but remains far below that required for deep convolutional neural networks. Inference Speed: Once trained, random forests provide extremely fast predictions. For a test set of 10,000 images, inference may complete in seconds on a standard CPU. These observations confirm that random forests can be deployed efficiently in production environments where computational resources are limited or latency is critical. 5. Implications for Practical Deployment 5.1 Use Cases Where Random Forests Excel Small to Medium-Dataset Scenarios: When the available labeled data is insufficient to train deep models effectively, random forests can still achieve reasonable performance. Feature-Rich Applications: If handcrafted features (e.g., color histograms, texture descriptors) capture enough discriminative information, random forests can exploit them efficiently. Resource-Constrained Environments: Devices with limited processing power or memory (mobile phones, embedded systems) can run random forest classifiers without the overhead of deep networks. Rapid Prototyping: Random forests require fewer hyperparameters to tune and are less sensitive to training data distribution, making them suitable for quick experimentation. 5.2 When Deep Learning May Be Preferable Despite their computational demands, CNNs can surpass random forests when: Large Datasets: With sufficient labeled examples (e.g., ImageNet), CNNs learn rich feature hierarchies that generalize well. Complex Visual Tasks: Fine-grained recognition, object detection, or segmentation often benefit from end-to-end learning and multi-scale representations. Transfer Learning: Pretrained CNNs can be fine-tuned on smaller datasets with relatively little data, leveraging learned low-level filters. 6. Conclusion The choice between Random Forest classifiers and Convolutional Neural Networks for image recognition hinges on a nuanced assessment of dataset size, computational resources, model complexity, and performance requirements. Random Forests offer simplicity, interpretability, and robustness with modest datasets, while CNNs excel when ample data and computing power are available to harness their powerful hierarchical feature learning capabilities. By systematically evaluating these factors_data volume, training time, inference speed, and desired accuracy_a practitioner can make an informed decision tailored to the specific constraints and objectives of their application. This analytical framework serves as a guide for navigating the trade-offs inherent in selecting an appropriate machine learning model for visual recognition tasks. References: anavar bodybuilding results	2025-10-01 16:09:22
内蒙古西北部秦汉长城调查记唐晓峰	[未验证] Amee	͆о�壺Śĉ?Ǝ��?&# https://holisticdoggie.com/uncategorized/%D0%B1%D0%B5%D1%81%D0%BF%D0%BB%D0%B0%D1%82%D0%BD%D0%B0%D1%8F-%D1%8E%D1%80%D0%B8%D0%B4%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F-%D0%BA%D0%BE%D0%BD%D1%81%D1%83%D0%BB%D1%8C%D1%82%D0%B0%D1%86%D0%B8%D1%8F/	2025-10-01 16:04:46
从居延汉简看汉代随军下层妇女生活贾丽英	[未验证] Nannette	�׀��捍ӾԑӺ杭� Ι realy enoyed visiting LED Display Manufacturer Ьecause іt ⲣrovides amazing solutions for modern display neｅds. Τhе products ⅼike LED Poster, LED Sign Board, аnd LED Wall Panel aге νery effective. I ɑlso appreciated tһｅ advanced LED Display 3D and Transparent LED Display opptions which make events attractive. Services like LED Wall Rental, LED Screen Rental, ɑnd LED Display for Events provide flexibility. Ϝߋr churches, solutions suhh ɑs Church LED Wall ɑnd LED Church Screen аｒе highly beneficial. Оverall, thе site іѕ a trusted LED Display Supplier and LED Screen Supplier worth recommending tο ɑnyone looking fοr professional LED Stage Screen, LED Screen Panels, оr LED Advertising Screen.	2025-10-01 15:56:35
长城边界与华夏边缘 ——读《中国的亚洲内陆边疆》夏晓莉	[未验证] Lucia	Єоr：长�Ǳ߽蔫华Є�ࠔ� I'm gone to say to my little brother, that he should also pay a quick visit this web site on regular basis to obtain updated from latest information. darknet market links https://market-darknet.org	2025-10-01 15:51:23
内蒙古西北部秦汉长城调查记唐晓峰	[未验证] Desmond	͆о�壺Śĉ?Ǝ��?&# Write more, thats all I have to say. Literally, it seems as though you relied on the video to make your point. You obviously know what youre talking about, why throw away your intelligence on just posting videos to your weblog when you could be giving us something informative to read? Also visit my web blog :: Thanks	2025-10-01 15:47:27
明代关西七卫与西番诸卫程利英	[未验证] Hildegarde	�̀�ķ�鈤�ǟπ&# Hey just wanted to give you a quick heads up and let you know a few of the pictures aren't loading properly. I'm not sure why but I think its a linking issue. I've tried it in two different web browsers and both show the same outcome. My blog post :: national addiction helpline	2025-10-01 15:47:04
明初土家族地区卫所设置考田敏	[未验证] Scarlett	ͯĴ：ķ��ӗ嶘ȸ&# Anavar Results: Complete Timeline, Safe Dosing & Cycle Protocols For Maximum Gains Comprehensive Guide on the Use of Drug X (e.g., Cortisol, Prednisone, Dexamethasone – any synthetic glucocorticoid) > Disclaimer > This document is for educational purposes only. It does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified clinician before starting, stopping, or modifying therapy with Drug X. --- 1. Pharmacologic Profile Parameter Description Drug class Synthetic glucocorticoid (steroid hormone analogue) Mechanism of action Binds cytosolic glucocorticoid receptor → translocates to nucleus → modulates transcription of >200 target genes: up‑regulates anti‑inflammatory proteins (e.g., lipocortin‑1), down‑regulates pro‑inflammatory cytokines (IL‑6, TNF‑α), inhibits NF‑κB & AP‑1 Receptor specificity Preferentially glucocorticoid receptor; minimal mineralocorticoid activity unless high doses Half‑life 2–3 h (systemic) but pharmacodynamic effects last 12–48 h due to genomic actions Metabolism Hepatic cytochrome P450 (CYP3A4, CYP1A2); glucuronidation; excreted in urine and bile Drug interactions Induced by rifampicin (↓ efficacy), inhibited by ketoconazole/clarithromycin (↑ levels) --- 2. Pharmacokinetic & Pharmacodynamic Rationale for the Dosing Regimen a) Loading Phase – 0.6 mg/kg IV every 8 h (48–72 h) Parameter Reasoning Loading dose Achieves plasma concentration >1 礸/mL rapidly, providing immediate therapeutic effect and preventing relapse of TB meningitis where bacterial burden is high. 0.6 mg/kg Approximately 2–3� the usual 0.4 mg/kg loading dose for non‑CSF infections; compensates for higher CSF penetration required in CNS disease (target CSF:plasma ratio ≈0.8). Every 8 h Shorter interval than typical 12 h ensures steady plasma levels due to increased clearance and potential drug–drug interactions with antitubercular therapy. Maintenance Phase Dose Frequency Rationale 0.4 mg/kg Every 12 h (standard) After achieving therapeutic CSF concentrations, maintenance can revert to standard dosing for most patients. Alternatively: 0.6–0.8 mg/kg every 24 h in patients with significant renal/hepatic impairment or those on interacting drugs (e.g., rifampin). Adjusted per organ function and interaction profile. Dose Adjustment Guidelines Renal Function - Creatinine clearance <30 mL/min: Reduce dose to 0.25–0.3 mg/kg every 24 h. - Clearance ≥30 mL/min: Standard or slightly increased dosing per above. Hepatic Function - Mild impairment (Child‑Pugh A): No adjustment required. - Moderate impairment (Child‑Pugh B): Reduce dose to 0.5–0.6 mg/kg every 24 h. - Severe impairment (Child‑Pugh C): Avoid use if possible; otherwise reduce to 0.3–0.4 mg/kg every 48 h. Drug Interactions - Concomitant rifampicin or other strong CYP3A4 inducers may increase clearance → consider dose escalation or therapeutic drug monitoring (TDM). - Strong CYP3A4 inhibitors (e.g., ketoconazole) may raise exposure → consider dose reduction. --- 6. Practical Guidance for Clinicians Situation Recommended Approach Baseline Start with standard dose; monitor sputum conversion at weeks 2, 4, and 8. Early non‑response (no conversion by week 4) Evaluate adherence; consider drug susceptibility testing; if resistant → switch regimen. Adverse reaction to one drug (e.g., fluoroquinolone toxicity) Substitute with alternative agent (e.g., levofloxacin for moxifloxacin) maintaining total potency. Drug–drug interaction (e.g., rifampin + CYP3A4 inhibitors) Adjust doses of interacting drugs; consider alternative regimens. Pregnancy Use WHO‑recommended regimen with careful monitoring; avoid teratogenic agents. Comorbidities (HIV, diabetes) Ensure ART compatibility; monitor for drug interactions and adherence support. --- 5. Summary & Practical Take‑aways Goal: Achieve microbiological cure in ≥ 95 % of patients while minimizing toxicity and resistance. Core Principles: Adequate pharmacodynamic coverage (AUC/MIC or %T>MIC) + high drug exposure + therapeutic monitoring. Monitoring Tools: Drug‑level assays, PK/PD modeling, culture/sensitivity results, safety labs. Adjustments: Tailor dosing based on levels, renal/hepatic function, drug–drug interactions, and patient-specific factors. Outcome: A systematic, data‑driven approach improves cure rates, reduces adverse events, and curtails the emergence of resistant strains. By integrating pharmacokinetics, pharmacodynamics, microbiology, and clinical monitoring into a cohesive framework, clinicians can optimize antimicrobial therapy to achieve the best possible patient outcomes. References: do steroids Make your penis bigger (https://www.valley.Md)	2025-10-01 15:45:37
明蒙隆庆和议前后边疆社会的变迁——以大同和丰州滩之间碰撞交流为中心全太锦	[未验证] Abdul	ȫ̫��Ȭ�Β& my web-site GameBeat slots & RTP guide	2025-10-01 15:42:55
与周汝昌老先生的一封信王洪启	[未验证] Josephine	ε�ꇴ：ԫלɪ��跕ᘒ Anavar Before And After: What Bodybuilders Look Like Before And After Anavar Effects Everything you need to know about taking collagen supplements \| Topic \| Key Take‑aways \| \|-------\|----------------\| \| What is collagen? \| The most abundant protein in the body; gives structure to skin, hair, nails, bones, joints and gut lining. \| \| Why people take it? \| Common reasons: improving skin elasticity, reducing joint pain, strengthening nails & hair, supporting bone health, aiding digestion. \| \| How is it made? \| Hydrolyzed (broken down) from bovine hides, marine fish skins or other animal sources. Hydrolysis turns collagen into a water‑soluble powder that’s easy to digest and absorb. \| \| Forms on the market \| Powder, capsules/tablets, ready‑to‑drink drinks, chewable gummies. \| \| Key ingredient \| Peptides (short chains of amino acids). Most commonly used peptides are: \| \| • Glycine (Gly) – 33% of collagen’s building blocks, provides structural stability and helps maintain elasticity. • Proline (Pro) – 13%, key for cross‑linking and strength in connective tissue. • Hydroxyproline (Hyp) – 14%, a modified proline that stabilizes the triple‑helix structure of collagen. • Arginine (Arg), Alanine (Ala), Glutamic acid (Glu), Lysine (Lys), etc., each contributing to skin, bone, cartilage and tendon health. \| Key take‑away: Collagen is a protein made up of amino acids—especially proline and hydroxyproline—which give it the unique triple‑helix structure that makes it strong yet flexible. --- ## 2️⃣ What Makes Collagen "The Building Block" for Body Functions? \| Function \| Why collagen matters \| \|---\|---\| \| Skin elasticity & hydration \| Collagen fibers fill gaps in the dermis; when they’re abundant, skin looks plump and firm. \| \| Joint health \| Cartilage is largely composed of proteoglycans that bind to collagen, giving it a cushion-like property. \| \| Bone strength \| The bone matrix consists of hydroxyapatite crystals embedded in collagen fibrils—collagen provides the framework for mineral deposition. \| \| Tendon & ligament resilience \| Dense collagen bundles transmit force from muscle to bone without tearing. \| \| Wound healing \| Fibroblasts produce new collagen at injury sites, forming scar tissue that restores integrity. \| > Key Insight: > Collagen’s triple‑helix structure is not just a structural scaffold; it also determines the mechanical properties (elasticity, tensile strength) of tissues and serves as a template for mineralization. --- ## 2. What Is Collagen Made Of? (Composition) \| Component \| Role / Function \| \|-----------\|-----------------\| \| Amino Acids (mainly Glycine, Proline, Hydroxyproline, Lysine) \| Provide structural stability; glycine allows tight packing of the helix; hydroxyproline and lysine contribute to cross‑linking. \| \| Post‑translational Modifications \| Hydroxylation of proline/lysine (requires vitamin C), glycosylation, phosphorylation. \| \| Cross‑links (dehydrodiferulate, pyridinoline) \| Stabilize the triple helix; formed enzymatically by lysyl oxidase. \| \| Collagen Fibril Assembly Proteins (e.g., decorin, biglycan) \| Regulate fibril diameter and spacing. \| --- ## 4. Collagen Types in the Skin \| Collagen \| Primary Location & Function \| \|----------\|----------------------------\| \| Type I \| Major structural collagen of the dermis; provides tensile strength; also found in epidermal basal layer, hypodermis. \| \| Type III \| Co‑together with Type I in reticular fibers; contributes to skin elasticity and resilience. \| \| Type IV \| Forms the basement membrane (BM) under the epidermis; critical for adhesion between dermis & epidermis. \| \| Type VII \| Anchoring fibrils of the BM zone; attaches BM to underlying dermis; essential for dermal‑epidermal cohesion. \| --- ## 2. Key Proteins and Their Functions \| Protein/Complex \| Location \| Function in Skin Integrity \| \|-----------------\|----------\|----------------------------\| \| Collagen I & III \| Dermal ECM (fibrous) \| Provide tensile strength, resist mechanical stress. \| \| Elastic fibers (Elastin + Fibulins) \| Dermis (especially subcutaneous) \| Allow skin to return to original shape after stretch. \| \| Laminin‑332 (α3β2γ2) \| Basement membrane \| Anchors keratinocytes to the BM; interacts with integrins α6β4. \| \| Integrin α6β4 \| Keratinocyte basal membranes \| Connects to hemidesmosomes; links to intermediate filaments. \| \| Hemidesmosomes (plectin, BP230) \| Keratinocyte–BM interface \| Provide mechanical linkage between keratinocytes and BM. \| \| Desmosomes (desmogleins, desmocollins) \| Epidermal cell‑cell junctions \| Ensure cohesive integrity of epidermis under tension. \| \| Intermediate filaments: Keratin 5/14 in basal layer; Keratin 1/10 in suprabasal layers. \| Structural scaffolding \| Provide tensile strength and resilience. \| --- ## Practical Tips for the Examination \| Focus Area \| Key Points to Remember \| \|------------\|------------------------\| \| Structural Hierarchy \| Skin → epidermis (stratified squamous) → dermis (dense irregular connective tissue). \| \| Cell Types & Functions \| Basal keratinocytes = proliferative; spinous layer = desmosomes, intermediate filaments; granular layer = lamellar bodies; stratum corneum = corneocytes + lipids. \| \| Adhesion Mechanisms \| Desmosomes (cadherins) → strong intercellular adhesion; hemidesmosomes (integrins α6β4) → attach basal cells to basement membrane. \| \| Extracellular Matrix Components \| Collagen I & III (tensile strength), elastic fibers, proteoglycans, laminin, fibronectin. \| \| Barrier Functionality \| Lipid lamellae prevent transepidermal water loss; tight junctions at the upper epidermis restrict paracellular transport. \| \| Repair/Regeneration \| Keratinocyte proliferation, migration into wound bed; re‑establishment of hemidesmosomes and ECM deposition for functional recovery. \| --- ## 3. How does this information guide surgical practice? \| Decision \| How the biology informs it \| \|----------\|----------------------------\| \| Incision depth & location \| Knowing that the epidermis is fragile, avoid deep incisions through it unless necessary; keep incisions within dermal layers to preserve vascular supply and hemidesmosomes. \| \| Suture choice \| Use fine, non‑absorbable or slowly absorbable sutures that do not pull on fragile epidermal tissue. \| \| Tissue handling \| Handle skin gently; avoid excessive traction that could detach epidermis from dermis. \| \| Closure technique \| Prefer simple interrupted or continuous sutures that distribute tension evenly, reducing risk of epidermal shearing. \| \| Post‑op care \| Protect incision with sterile dressings and advise minimal movement to prevent dehiscence; educate on signs of infection due to compromised skin barrier. \| --- ## 4️⃣ How to Use This Sheet in Practice 1. Before the Procedure - Quickly scan the "Key Points" section to remind yourself of the main risk factors. - Check that you have a gentle closure plan ready. 2. During the Procedure - Keep the sheet visible; refer to it when choosing suture type or applying tension. 3. After the Procedure - Use the "Post‑op Care" section as a checklist for patient instructions and follow‑up appointments. 4. Keep Updated - If new evidence emerges, replace or update the relevant sections while keeping the rest intact. --- ### Final Thought A well‑organized cheat sheet is like a seasoned assistant—ready to provide quick, reliable guidance whenever you need it. By focusing on the most critical points and presenting them in a clear, accessible format, you’ll reduce stress, avoid mistakes, and give your patients the best possible care. Happy stitching! References: Anabolic supplements reviews (https://www.valley.Md)	2025-10-01 15:41:46
明辽东长城与清柳条边邸永君	[未验证] Donette	ۡԀ�틓�ɶこȓ숥�X Understanding The Anavar Cycle: Duration, Goals, And Results Comprehensive Marketing Strategy For a Mental‑Health Services Company (Therapy & Counseling) > Goal: Position the firm as the trusted, evidence‑based partner for anyone seeking mental‑health support—whether they’re facing anxiety, depression, life transitions, or trauma. Build brand awareness, generate qualified leads, and nurture patients into long‑term, engaged clients. --- 1. Brand Pillars & Messaging Framework Pillar Core Message Supporting Tone Trust "Your mental health matters. We’re here to help you safely." Warm, reassuring, professional Expertise "Clinically‑backed care from board‑certified clinicians." Knowledgeable, confident Accessibility "Convenient online & in‑person options tailored to your life." Friendly, flexible Empowerment "You’re not alone—let’s build resilience together." Motivational, supportive Use the pillars as a filter for all content: if it doesn’t align with these themes, revise or discard. --- 3. Core Content Pillars A. Educational Posts "Did You Know?" facts about mental health conditions (e.g., anxiety prevalence). Mini‑videos explaining coping strategies. Infographics summarizing therapy modalities. Frequency: 2–3 per week on the main feed, plus stories for quick tips. B. Success Stories / Testimonials Short video or quote from a patient (with consent) describing progress. "Case study" carousel posts breaking down challenges and outcomes. Frequency: 1–2 per month. Keep content authentic; avoid overly dramatic dramatization. C. Behind‑the‑Scenes (BTS) Quick snapshots of the clinic environment, staff introductions. "Day in the life" stories featuring a therapist or patient volunteer. Frequency: As part of weekly stories, occasional reel. D. Educational Live Sessions / Q&A Host live sessions on topics like coping with anxiety, therapy myths. Encourage viewer questions; answer briefly and direct them to consult services. Frequency: 1 per quarter for in‑house experts; partner with influencers for joint sessions. 4️⃣ Content Formats & Creative Ideas Format Ideal Use Tips Reels (15‑30s) Quick tips, myth busting, behind‑the‑scenes snippets. Keep captions short; use trending music or sounds; add a call‑to‑action ("DM us for more"). Carousel Posts In‑depth guides, step‑by‑step processes. 3‑7 slides max; each slide should be self‑sufficient yet flow naturally. Stories (including Highlights) Daily updates, polls, Q&A, "a day in the life" vignettes. Use stickers to encourage interaction; save key stories as Highlights for newcomers. IGTV / Reels Longer tutorials or fast‑paced tips that fit within a 30‑second limit (Reels). Optimize captions with relevant keywords and hashtags. Live Sessions Real‑time engagement, interviews with experts. Announce in advance; interact via comments; use the "Follow" button to attract new followers. --- 4️⃣ Content Pillars for Your Profile Organize your posts around the following pillars so you always have a clear focus and can schedule content more easily: Pillar Purpose Example Post Types 1. Foundations Introduce core concepts of behavioral science (e.g., loss aversion, social proof). Carousel explaining "What is Cognitive Bias?" with infographics; Reel summarizing a bias in 15 seconds. 2. Practical Applications Show how to apply theory in real life or business contexts. Case study reel: "How A/B testing saved $10k for X company"; Infographic of step-by-step implementation. 3. Tools & Resources Share software, books, podcasts, and frameworks. Reel reviewing a behavioral analytics tool; Carousel listing 5 must-read books. 4. Community Engagement Encourage followers to share their experiences or ask questions. Q&A story: "Ask me anything about behavioral economics"; Post with prompt: "Share your biggest bias moment." 5. Behind-the-Scenes / Personal Story Build authenticity by sharing your learning journey, challenges, etc. Reel of a day in the life; Carousel of early mistakes and lessons learned. --- 3️⃣ Content Production Workflow 3.1 Planning (Weekly) Time Task Output Mon – 2 h Brainstorm: Use tools like Notion/ Trello to gather ideas from industry news, research papers, and audience feedback. Create a "Content Calendar" board with 5–6 post topics for the week. Tue – 1 h Scriptwriting: Draft concise scripts (≤2 min) in bullet form; include hook, key points, CTA. Save in Google Docs or Notion. Wed – 30 min Storyboard/Visual Prep: Outline visuals—slides, on‑screen text, callouts. Use Canva for slide design and PowerPoint for transitions. Thu – 1 h Rehearse: Record a dry run (no editing) to check pacing, tone, and clarity. Review and adjust script if needed. Production Hardware: Logitech C920 webcam; Rode NT‑USB mic with pop filter; ring light or softbox for even lighting. Software: OBS Studio for recording; DaVinci Resolve 17 (free version) for editing; Canva/PowerPoint for slides; Adobe Audition for audio cleanup if needed. Post‑Production Import footage into DaVinci Resolve. Sync video with slide deck, add captions and callouts. Clean up audio: remove background hiss, apply a high‑pass filter at 80 Hz. Export in H.264 (MP4) at 1080p, 30 fps. Quality Control Verify that the video plays smoothly on YouTube and Vimeo. Confirm captions are accurate; test with screen readers for accessibility compliance. 2. Audio‑Only Podcast Episode a. Recording Setup Component Specification Microphone Shure SM7B (dynamic) Preamp Cloudlifter CL-1 + Focusrite Scarlett 2i2 (USB audio interface) Headphones Audio-Technica ATH-M50x Software Audacity (free, cross‑platform) Environment Sound‑treated room; use a boom arm and pop filter Why these choices? Shure SM7B: Provides low self‑noise, flat frequency response, and excellent rejection of room noise—ideal for voice recordings. Cloudlifter: Boosts the mic signal without adding distortion, allowing the Scarlett 2i2 to deliver a clean gain curve. Focusrite Scarlett 2i2: Reliable USB interface with high‑quality converters (48 kHz/24 bit), sufficient for podcasting. Audacity: Free, open source, and fully capable of multi‑track editing and effects. Recording Workflow Set Up Microphone: - Mount the SM7B on a stable boom arm. - Use a pop filter to reduce plosives. - Ensure no background noise (turn off fans, close windows). Configure Scarlett 2i2: - Connect USB to computer; install drivers if needed. - Set input gain to ~0 dB on the console. - Enable phantom power (+48 V) for SM7B. Launch DAW (e.g., Audacity, Reaper): - Create a new project. - Add an audio track; set input to Scarlett 2i2 channel. - Arm track for recording; monitor latency (~20‑30 ms acceptable). Record: - Hit record and speak clearly into mic. - Stop when finished. Edit & Export: - Trim silence, adjust volume levels. - Export as MP3 (320 kbps) or WAV for highest quality. Transfer to Phone: - Copy file via USB, cloud storage, or Bluetooth. - Open in phone’s audio app and set as ringtone. Result: Clear, high‑quality voice recording suitable for use as a ringtone on any modern smartphone. --- 2. Recording the Voice of a Person (e.g., an Elderly Relative) A. Preparing the Environment Step Purpose Choose a Quiet Room Minimize background noise and echoes. Set Up Microphone Use a lapel mic or a good quality USB condenser mic; place it ~15–20 cm from the speaker’s mouth, slightly off‑center to avoid popping. Use a Pop Filter / Foam Cover Reduces plosive sounds (p, t, k). Close Doors/Windows Prevents external noise leakage. Check Power & Batteries Avoid interruptions due to low battery or dead mic. Recording Workflow Software Setup - Open Audacity. - In the drop‑down menu near the record button, choose the correct input device (e.g., "USB Audio Device"). - Set recording level: Click Transport → Record with a short test clip; adjust sliders until the waveform peaks around –12 dBFS to –6 dBFS. - Enable Tracks → Add New → Mono. Test & Calibration - Ask the speaker to say a simple sentence: "I am recording for my podcast." - Stop recording, play back, and confirm clarity. Full Recording Session - Press Transport → Record (or press "R" on keyboard). - The track header turns red; all input signals start being captured. - Monitor the audio level meter to keep levels steady; if too loud, lower mic gain; if too soft, raise it. Stopping & Saving - Press Space or click "Stop" when finished. - Use the "Save Project" button or `Ctrl+S` (Windows) / `Cmd+S` (macOS). - Choose a location and name for your project file (`*.kdenlive`). Exporting - For final output, go to `File → Render`. - Pick the format (e.g., MP4), resolution, and click "Render." --- �� Quick Tips for Beginners Tip Explanation Use Keyboard Shortcuts Speed up editing. E.g., `Ctrl+Z` undo, `Ctrl+C/V` copy/paste clips. Organize Clips in Bins Drag clips into bins named "Video," "Audio," "Music." Keeps timeline tidy. Set In/Out Points Press `I` to set start, `O` to set end before dragging clip onto the timeline. Use Keyframes for Volume Right‑click audio track → Add keyframe to fade volume in/out. Export Regularly Save project frequently (`Ctrl+S`). Avoid losing work due to crashes. --- 4. How to Export a Video 4.1 Basic Export Settings (MP4) In the Project Manager, right‑click your timeline or sequence → Render. In the Render dialog: - Format: `H.264` (for MP4). - Resolution: Match your source resolution or set a custom one. - Bitrate: 10–20 Mbps for HD, higher if needed. Click Export. 4.2 Using Adobe Media Encoder From the sequence window, choose File → Export → Media. In the Export Settings dialog: - Format: `H.264`. - Preset: Choose an appropriate one (e.g., `YouTube 1080p Full HD`). Click Queue to send it to Adobe Media Encoder. In Media Encoder, start the queue. 4.3 Exporting as GIF In After Effects, create a composition with your animation. Go to File → Export → Add to Render Queue. Set Format to `Animated PNG` or `GIF`. Configure the output settings and click Render. Frequently Asked Questions (FAQs) \| \| Question \| Answer \| \|---\|----------\|--------\| \| 1 \| Do I need a subscription to use these tools? \| Some features are free; premium versions may require payment, but most basic functionalities are available without a subscription. \| \| 2 \| What file formats can I export from After Effects or Premiere Pro? \| Common exports include MP4 (H.264), MOV (ProRes/QuickTime), GIF, PNG sequence, and WebM for browsers. \| \| 3 \| Can I use these tools on a Mac? \| Yes—Adobe products run on macOS; many online editors support both Windows and macOS. \| \| 4 \| Is there a learning curve? \| Basic tutorials are quick; complex projects benefit from dedicated courses or YouTube guides. \| \| 5 \| Can I create animations for social media using these tools? \| Absolutely—design story‑style videos, animated posts, reels, and TikTok clips with the same workflow. \| --- Quick‑Start Guide Pick Your Tool - Want full control? Use Adobe After Effects or Premiere. - Need something fast? Try Canva, Kapwing, or Renderforest. Create a New Project - Choose the correct aspect ratio (e.g., 1080 � 1920 for stories). Add Elements - Background: solid color, gradient, or video clip. - Text/Graphics: drag‑and‑drop or type in. - Animations: apply preset keyframes (fade, slide, bounce). Fine‑Tune Timing - Adjust the duration of each layer to sync with music or narration. Export - Render as MP4 at 30 fps, resolution 1080p. Upload - Add captions/hashtags if needed before posting. �� Quick Reference Cheat Sheet Step Action Tool/Shortcut 1 Create new project `File → New` 2 Import media Drag‑drop or `Ctrl+I` 3 Trim clip Select > `Razor` tool (C) 4 Add fade Clip > `Opacity Keyframes` 5 Adjust color `Color Correction Panel` 6 Export `File → Export → Media` (`Ctrl+M`) --- �� Final Thoughts Practice: The more you experiment, the faster you'll learn. Stay Curious: Try new effects and plugins—each will teach something. Share & Iterate: Show your work to friends or online communities; feedback accelerates growth. Happy editing! If you ever get stuck, feel free to ask for help—you’re on a promising path. �� --- Feel free to copy this guide into any document or note-taking app and tweak it as you learn more about your specific video editor. Good luck, and enjoy creating amazing videos! References: also En Ingles	2025-10-01 15:41:25
伊比利亚文献对长城早期记载一瞥金国平、吴志良	[未验证] Eric	��健�Ϣ־\|：Ӂ�ɀ&# 39 Anavar Cycle Results That Dissolve Fat, Boost Strength And Harden Your Physique Articles And Blog Quick Guide to Using Anavar (Oxandrolone) > Disclaimer: This guide is for informational purposes only. > Always consult a qualified healthcare professional before starting any supplement or medication, especially if you have pre‑existing conditions or are taking other drugs. --- 1. What Is Oxandrolone? A synthetic anabolic steroid derived from dihydrotestosterone (DHT). Low androgenic activity → minimal risk of virilization in women and men. Widely used for: - Muscle wasting (e.g., chronic illness, injury recovery) - Anabolic support during cutting phases - Enhancing strength & endurance without excessive water retention --- 2. Typical Dosage & Cycle Structure Phase Dose Duration Week 1–4 (loading) 10 mg BID 4 weeks Weeks 5–6 (maintenance) 20 mg daily (single dose) 2 weeks Total cycle length: ~6 weeks Why this split? - Lower doses early allow the body to adapt, reducing GI upset and androgenic side effects. - The maintenance phase delivers a steady-state concentration sufficient for muscle growth without provoking excessive estrogen conversion. > Caution: These numbers are based on typical dosage ranges reported in bodybuilding forums. Individual responses vary; always consider personal tolerance and consult a professional if possible. Post-Cycle Therapy (PCT) While the cycle Is steroid a protein short, the body’s natural testosterone production can be suppressed temporarily: Selective Estrogen Receptor Modulators (SERMs) - Clomiphene or Tamoxifen: 50 mg/day for 5–10 days, then taper off. Optional aromatase inhibitor if estrogen spikes are noted: Anastrozole 0.25 mg/day for a few days. The PCT helps restore endogenous hormone levels and mitigate side effects like gynecomastia or mood swings. Practical Tips & Safety Considerations Issue Recommendation Dosage Stick to the conservative schedule above; avoid "more is better." Monitoring Keep a log of weight, strength gains, mood changes. If you notice acne, hair loss, or emotional swings, adjust dosage or stop temporarily. Legal status In many countries, SARMs are not approved for human use and may be sold as research chemicals; purchasing from reputable sources is essential to avoid counterfeit products. Drug interactions Avoid concurrent use of other steroids or performance enhancers unless you’re certain about cumulative estrogenic effects. Long‑term safety No large‑scale, long‑term studies exist; consider this a short‑term intervention with unknown lasting impacts on liver function and cardiovascular health. --- Quick Summary Aspect Key Points Goal Build muscle (≈3–4 kg) while keeping weight stable for an event. Protocol 8‑week cycle of low‑dose Anavar (15 mg/day), progressive strength training, 0‑5 g carbs per day, ~1 L water daily, no added estrogen blockers. Safety Monitor liver enzymes, blood pressure, cholesterol; watch for gynecomastia or mood changes. Effectiveness Expected ~3–4 kg lean gain if diet and training are optimal; weight will not increase significantly due to low carb intake. --- Bottom‑Line Takeaway A low‑dose Anavar cycle (≈15 mg/day for 8 weeks) combined with a very low carbohydrate intake (~0‑5 g/day), plenty of water, and disciplined resistance training can produce ~3–4 kg of lean mass without appreciably increasing overall body weight. The key is to keep net calories close to maintenance while ensuring sufficient protein and strength stimulus; the anabolic effect of Anavar will then convert that protein into muscle rather than fat. No significant rise in weight occurs because carbohydrate stores are minimal, and the caloric surplus needed for fat gain is avoided. Feel free to ask if you'd like details on meal planning or training protocols!	2025-10-01 15:40:55
夏至战国中国北方长城地带游牧文化带的形成过程（论纲）上林沄	[未验证] Calvin	–›V：Єׁս�꼃�北方� Oxandrolone Anavar: Bodybuilding Guide Short‑form guide to Oxandrolone (Anavar) \| Section \| Take‑away \| \|---------\|-----------\| \| What it is \| A synthetic anabolic steroid derived from testosterone; marketed as "a mild" steroid but still powerful enough for muscle gain, fat loss and improved recovery. \| \| Why bodybuilders use it \| • 30–40 % more lean muscle mass per week (without huge weight gains) • 8–20 % faster fat loss when paired with diet • 10‑15 % stronger lifts (especially in bench press, deadlift, squat). \| \| Typical cycle \| • 4–6 weeks of 30–50 mg/day (or 3�10 mg/5 days) • Followed by a post‑cycle therapy (PCT) such as Clomid or Nolvadex to restore natural testosterone. \| \| Why it works \| • Enhances protein synthesis and nitrogen retention, giving leaner muscle • Improves recovery; less muscle soreness, quicker next‑day performance. \| \| Side‑effects \| • Mild: acne, hair loss, hot flashes, mood swings • Rare but serious: gynecomastia (treated with PCT), high blood pressure, liver strain. Monitoring is essential if used regularly. \| \| Legal status \| In many countries it is a prescription-only medication; possession without a prescription can be illegal. \| --- ### Bottom‑line If you’re looking for an extra edge in the gym—more power during lifts, faster recovery, or a boost to your overall performance—a short course of a testosterone‑enhancing drug can help, but it comes with risks and legal ramifications. Use only under medical supervision, be aware of the side‑effects, and stay compliant with local laws. For most people, a solid training program plus proper nutrition remains the safest path to better results. References: relevant Webpage at Valley md	2025-10-01 15:39:43
大同长城保护与利用现存问题的原因分析刘媛	[未验证] Marianne	�炣捍��こǱ；�ԫ{ԃЖ Test Primo Anavar Cycle Results, Today I Talk About My Use Of Anavar I’m sorry, but I can’t help with that. References: anabolic supplement reviews	2025-10-01 15:39:13
汉长城预警体系研究特日格乐	[未验证] Bob	͘ɕ��汉撼こȔぞ�ͥϵ Anavar Cycle: Key Information And Frequently Asked Questions I’m sorry, but I can’t help with that. References: read more on valley`s official blog	2025-10-01 15:39:04
西平亭考辨巢生祥	[未验证] Will	巢ʺЩ：Ϸƽͤ考�䠡� 长�Ȑ Anavar Review: Side Effects, Dosage, Results In 2025 Thanks for sharing all that detail! What would you like me how long to see results from anavar do with this information—summarize it, analyze specific parts, help draft a strategy, or something else?	2025-10-01 15:38:05
明长城宣府镇西路城堡考张依萌	[未验证] Star	օӀĈ：ķ长�Ȑ큽�Ϸ Anavar Cycle Aldo (generic name = Insert generic drug name) – Quick‑Reference Guide \| Feature \| Details \| \|---------\|---------\| \| Common indications \| • Primary disease/condition treated • Secondary indication, if any \| \| Typical dosing \| • Adults: X mg PO once daily (� Y mg) • Children: Z mg/kg PO twice daily (max. W mg) \| \| Route of administration \| Oral (tablet/capsule), sometimes as a liquid formulation for pediatric use \| \| Key safety points \| • Contraindicated in patients with specific contraindication • Requires monitoring of lab value every N weeks \| --- ### 4. Clinical Context & Evidence - Guideline Position: In the latest Clinical Guideline, Aldara is recommended for patients who have failed first‑line therapy (e.g., topical steroids) and are unwilling or unable to undergo surgical excision. - Evidence Level: The pivotal phase III trial comparing Aldara to placebo demonstrated a statistically significant reduction in lesion size with an acceptable safety profile. Meta‑analyses of 4 RCTs show pooled risk ratios favoring Aldara for complete response (RR = 1.54, 95% CI 1.20–1.98). - Comparative Effectiveness: While surgical excision remains the gold standard with cure rates >90%, Aldara offers a non‑invasive alternative that preserves tissue and avoids anesthesia. --- #### 5. Decision Aid \| Option \| Pros \| Cons \| \|--------\|------\|------\| \| Surgical Excision \| • Definitive cure < 10% recurrence • Histology confirms margins \| • Requires general or regional anesthesia (age‑appropriate) • Post‑op pain, risk of infection • Possible scarring \| \| Topical Aldara (Imiquimod) \| • Non‑invasive; no anesthesia • Can be applied at home • Preserves surrounding tissue \| • Requires 2–3 months of daily use • Local irritation, redness, itching • Systemic flu‑like symptoms possible \| \| Observation \| • Avoids procedures and medication side effects \| • Tumor may grow, become symptomatic or invasive; delayed treatment \| --- ## 5. Practical Decision‑Making Flow 1. Confirm diagnosis If atypical/uncertain → biopsy → histology. 2. Assess tumor size - < 1 cm: Consider daily topical therapy (curettage + curettage). - ≥ 1 cm: Proceed to step 3. 3. Determine treatment modality - Surgery preferred for lesions ≤ 5 mm or with high risk of recurrence, if patient is fit for local anesthesia and surgery is feasible. - Topical therapy (daily curettage) for larger lesions (> 5 mm) or when surgical excision would cause significant morbidity. 4. Plan follow‑up - For daily curettage: weekly check-ups until complete clearance (typically 4–6 weeks). - For surgery: routine postoperative visits at 2 and 6 weeks, then yearly screening for recurrence. --- ## Bottom‑Line Takeaway - All lesions > 5 mm should be treated—no "watchful waiting" is acceptable. - Surgical excision is appropriate for small (< 5–7 mm) lesions where it can be performed with minimal morbidity. - Daily curettage (or another minimally invasive technique) is the preferred approach for larger (> 5 mm) lesions or those in cosmetically sensitive areas. Adopting this algorithm will streamline decision‑making, reduce unnecessary procedures, and improve patient outcomes. References: find out more at Valley md site	2025-10-01 15:37:49
内蒙古西北部秦汉长城调查记唐晓峰	[未验证] Gretchen	͆о�壺Śĉ�Ǝ��&# A major advantage about 360 is its all-in-one approach to online security and tools. Ԝhile browsing 360安全, 360卫士, ɑnd 360杀毒, Ι found them highly reliable. The downloads like 360下载 and 360安全卫士下载 аге secure. Tools ѕuch ɑѕ 360驱动, 360驱动大师, and 360压缩 ensure smooth performance. Ӏ also noticed tһe neat sction fоr 360官网 and 360软件管家. Ƭһіs confirms thɑt tthe site іѕ reliable. І recommend ｅveryone tⲟ give іt a try.	2025-10-01 15:35:12
1644至1911年陕北长城外伙盘地垦殖时空特征分析——以榆林金鸡滩乡为例王晗	[未验证] Kerry	ε돣�1644ׁ1911Ūʂ北长�ȍ⼯ Anavar For Women And Men: CrazyBulk Launch anavar 1 cycle results Legal Steroid Alternative For Female Read Dosage, Side Effects, Before And After Cycle Results Benchmarking the Body: Why "The Benchmark" Is Now the Go‑To Standard in Fitness For years, fitness enthusiasts have chased vague goals—"lose 10 lbs," "run a sub‑5 k." These targets are helpful, but they’re also subjective and hard to track. Enter The Benchmark, a scientifically calibrated reference point that turns nebulous objectives into concrete, measurable milestones. Precision: Each Benchmark score is derived from validated physiological data—VO₂ max, resting heart rate, body fat percentage, and more. Personalization: Scores are adjusted for age, sex, ethnicity, and activity level, giving you a realistic snapshot of where you stand. Progression: By regularly testing against the Benchmark, you can see incremental gains in fitness, strength, or body composition. In essence, the Benchmark transforms your training plan from vague aspirations into a structured, data-driven roadmap. How to Use a Fitness Tracker Effectively for Your Goals? Fitness trackers are ubiquitous, but many users don't exploit their full potential. To truly benefit, consider these strategies: Define Specific Objectives: Are you aiming for weight loss, increased endurance, or muscle gain? Each goal requires distinct metrics. Set SMART Goals (Specific, Measurable, Achievable, Relevant, Time-bound). Write them down; trackers provide the data, but self‑discipline is essential. Sync Data Regularly: Most trackers require syncing to cloud platforms. Ensure you do this weekly so your insights are accurate and actionable. Use Built‑in Coaching Features. Many devices have coaching prompts (e.g., "Let’s move for 10 minutes"). These can be leveraged to stay on track. Review Trends Monthly. Look at weekly averages, compare with goals, adjust accordingly. The dashboard is a powerful visual tool; let it inform your next steps. --- ## Final Thought If you’re ready for a data‑driven approach that keeps you accountable and gives you the clarity to reach your health goals, I can help you set up an automated system that works around the clock. Just reply "I want the system" and we’ll get started. Thanks for reading! —Your Name --- TL;DR – Want a fully automated tracking and reporting system? Reply "I want the system."	2025-10-01 15:35:09
夏至战国中国北方长城地带游牧文化带的形成过程（论纲）下林沄	[未验证] Danuta	–›V：Єׁս�꼃�北方� Anavar Results: Before & After Pics Week By Week Comprehensive Guide to a Popular Weight_Loss & Energy Supplement > Disclaimer > This document is intended for informational purposes only. It does not replace professional medical advice, diagnosis or treatment. Consult a qualified healthcare provider before starting any new supplement, especially if you have an existing medical condition or are taking prescription medication. --- 1. What Is It? The product in question is a dietary supplement marketed primarily as a weight_loss aid that also provides a noticeable energy boost. Typical claims include: "Helps burn fat" _ through thermogenic (heat_producing) effects. "Increases metabolism" _ raising the basal metabolic rate. "Improves focus and energy" _ via stimulants such as caffeine. It is sold in powder form, intended to be mixed with water or a beverage. Many brands use similar ingredients but may differ slightly in concentration or additional "helper" compounds (e.g., antioxidants, vitamins). 2. How the Product Works Mechanism What it does Key Ingredients Thermogenesis Raises body temperature _ burns calories Caffeine, green tea catechins (EGCG), capsaicin (optional) Central Nervous System Stimulation Increases alertness & focus Caffeine, L-theanine, small amounts of guarana or yerba mate Metabolic Rate Increase Accelerates fat oxidation Green tea extract, forskolin (controversial), niacin Appetite Suppression Reduces cravings Chromium picolinate, glucomannan, phenylalanine Hydration & Diuresis Aids in detoxification Dandelion root, cayenne pepper (low dose) > __ Note: Many of these ingredients are still under investigation. While caffeine is well-documented for its thermogenic effect, substances like forskolin or phenylalanine have limited evidence and may carry side effects such as increased heart rate, hypertension, or serotonin syndrome when combined with other stimulants. --- 3. Why the Current Formula Might Be "Missing" Lack of a Strong Thermogenic Backbone The existing mix includes caffeine but no additional thermogenics (e.g., capsicum derivatives, synephrine). As a result, metabolic rate increases only modestly and may not sustain a prolonged calorie burn. No Appetite Suppression or Satiety Signals Without compounds that delay gastric emptying (like glucomannan) or modulate leptin/ghrelin, the user might still feel hungry after ingestion, undermining weight_loss potential. Insufficient Energy Expenditure Boost The formula doesn_t provide a clear pathway to elevate resting metabolic rate by at least 5_10_%_a target often cited for meaningful weight loss over time. Potential Thermogenic Ceiling Some ingredients (e.g., high_dose catechins) may reach a plateau where additional dosage yields diminishing returns, and could even trigger adverse effects such as jitteriness or elevated blood pressure. 2. How the Product May Help Weight Loss Mechanism Why it matters for weight loss Increased thermogenesis Raises total daily energy expenditure (TDEE) by burning more calories at rest and during activity. Appetite suppression Reduces caloric intake through satiety signals or decreased hunger hormones, leading to a negative energy balance. Improved insulin sensitivity Enhances glucose uptake in tissues, lowering post_prandial blood sugar spikes that can otherwise promote fat storage. Enhanced fatty acid oxidation Shifts metabolism from carbohydrate utilization toward burning stored triglycerides. Mood and stress modulation Lower cortisol levels reduce the tendency to overeat or store visceral fat under stress conditions. --- 3. Mechanistic Overview of Key Ingredients Ingredient Primary Active Compound(s) Molecular Target(s) Effect on Energy Balance Lemon (Citrus limon) Hesperidin (flavonoid), Vitamin C Aryl hydrocarbon receptor (AhR), Nuclear factor-_B (NF__B) Anti_inflammatory; improves insulin sensitivity; may increase thermogenesis via PPAR_ activation. Citrus aurantium (Bitter Orange) Synephrine (__adrenergic agonist) __, __ adrenergic receptors _Heart rate & metabolic rate _ increased energy expenditure (~5_10% of resting metabolism). Hibiscus sabdariffa (Roselle) Anthocyanins, Vitamin C AMP_activated protein kinase (AMPK) Lowers lipogenesis; improves lipid profile. Lemon Citric acid, flavonoids CoA ligase activation Enhances fatty acid oxidation in mitochondria. Peppermint Menthol, essential oils TRPM8 & TRPA1 channels (cold-sensing) Creates cooling sensation _ reduces perceived exertion. Ginger Allicin, gingerol Cyclooxygenase inhibition Anti_inflammatory, improves circulation. 4.2 Mechanistic Pathway from Ingestion to Performance Ingestion & Absorption - Vitamin C, B_vitamins, and minerals are absorbed in the small intestine via active transport or passive diffusion. - Essential oils (peppermint, ginger) enter systemic circulation via capillaries. Metabolic Modulation - Vitamin C enhances recycling of oxidized glutathione, preserving NADPH for antioxidant enzymes. - B_vitamins facilitate conversion of pyruvate to acetyl_CoA (__oxidation) and NADH production in the TCA cycle, boosting ATP synthesis. - Minerals act as cofactors: Mg瞋 stabilizes ribosomal RNA, Ca瞋 regulates mitochondrial membrane potential. Oxidative Stress Mitigation - Antioxidant enzymes (SOD, CAT, GPx) neutralize ROS, preventing lipid peroxidation of mitochondrial membranes. - Reduced ROS levels lower the activation of NF__B signaling pathways that trigger inflammatory cytokine release. Cellular Recovery and Adaptation - Lower oxidative damage allows maintenance of protein folding capacity in the endoplasmic reticulum (ER), reducing ER stress markers like GRP78/BiP. - Stabilized mitochondria preserve ATP production, ensuring energy availability for repair processes such as autophagy. Quantitative Illustration Assume that during a typical metabolic burst: ROS generation increases by ~3� relative to basal levels due to high mitochondrial activity. The supplement reduces ROS production by 30% (i.e., effective ROS = 0.7 � (basal + excess)). Oxidative damage markers such as protein carbonyls rise linearly with ROS exposure time. If the metabolic burst lasts for 5 minutes, and basal ROS leads to a baseline oxidative damage level of 1 arbitrary unit, then: Scenario Excess ROS Factor Total ROS (units) Oxidative Damage Basal 1.0 1.0 1.0 Burst 2.5 3.5 3.5 Burst + Metabolic Boost 4.0 5.0 5.0 With metabolic boost, the oxidative damage increases significantly due to higher ROS production. Implications Increased Oxidative Stress: The surge in ROS leads to oxidative stress, damaging cellular components such as lipids, proteins, and DNA. Impact on Cell Function: Damage to mitochondria can impair ATP production, potentially leading to energy deficits in the cell. Cellular Signaling Alterations: Elevated ROS levels may affect signaling pathways, possibly triggering apoptosis or inflammatory responses. Potential Therapeutic Interventions: - Antioxidant treatments (e.g., N-acetylcysteine) might mitigate oxidative damage. - Modulating mitochondrial function could reduce ROS production. Conclusion The "Boost" protocol, when combined with a "Boosting" metabolic state, leads to a significant increase in mitochondrial activity and ROS production. While this may be beneficial for certain cellular functions, it also raises the risk of oxidative stress and potential damage. Understanding these effects can help in designing strategies to balance energy demands while protecting cells from oxidative harm. --- 2.1 Overview The following section introduces a new method for estimating protein-protein interaction (PPI) networks using only sequence data: a simple, sequence-based scoring system that predicts interactions among proteins. This approach uses known protein structures to train a model that scores pairs of protein sequences based on how likely they are to interact. --- 2.1 The PPI-SeqNet Algorithm 2.1 Overview The proposed method is called PPI-SeqNet, and it works as follows: For each protein, obtain a feature representation from its sequence (e.g., using embeddings or profiles). For every pair of proteins $ i $ and $ j $, compute a score indicating how long for anavar to work - www.valley.md, likely they interact. Use the scores to rank potential interactions. 2.2 Model Training We trained PPI-SeqNet on known interacting protein pairs from curated databases. The training objective is to maximize discrimination between positive (interacting) and negative (non-interacting) pairs, typically using a binary cross_entropy loss or ranking loss. --- Experimental Results Below are the primary quantitative results from our evaluation: Metric PPI_Score (Baseline) PPI_Score + $ \Delta_ij $ AUROC 0.842 0.904 AUPRC 0.761 0.825 F1_score 0.68 0.75 The improvements are statistically significant (p_<_0.001) as assessed by a two_sample t_test on cross_validation folds. In addition to global metrics, we observed that the inclusion of $ \Delta_ij $ particularly enhances predictive performance for low_confidence interactions_those with sparse experimental evidence. This aligns with our hypothesis that structural compatibility can compensate for limited data. --- 3. Discussion 3.1 Interpretation of Results The quantitative gains demonstrate that incorporating a physics_based interaction energy term augments the purely data_driven model. The energy term likely serves as an additional regularizer, guiding the learning algorithm toward physically plausible predictions and reducing overfitting to noise in the training data. Furthermore, the fact that improvements are more pronounced for low_confidence interactions suggests that structural information provides valuable complementary evidence when experimental annotations are scarce or ambiguous. 3.2 Limitations Despite encouraging results, several caveats must be acknowledged: Assumptions in Energy Calculations: The use of a simple Lennard_Jones potential neglects solvent effects, electrostatics, and entropy contributions, potentially limiting the fidelity of the energy estimates. Static Structures vs Dynamics: Protein structures used are static snapshots; real proteins exhibit conformational flexibility that can influence binding interfaces. Data Quality and Coverage: Structural data availability is uneven across protein families, which may bias the analysis toward well-characterized systems. Model Generalizability: The models were trained on specific datasets (e.g., KEGG pathways), and their applicability to other biological contexts remains to be validated. 5. Conclusion By integrating structural information with statistical modeling of biochemical interactions, we can better understand the determinants of protein-protein associations within metabolic networks. While challenges remain_particularly regarding dynamic conformational changes_the present framework demonstrates that binding affinities and geometric complementarity are essential components in predicting functional interactions. Future work should focus on incorporating molecular dynamics simulations to capture transient structural states and expanding datasets to include diverse biological systems, thereby enhancing the predictive power and universality of such models.	2025-10-01 15:35:07
明初军额考张松梅	[未验证] Hanna	օ̉鳎�ķ�� …… 长�4 anavar 30 day results Tablet Oxandrolone Uses, Side Effects, & More It looks like you’ve pasted a draft of an email. How would you like me to help with it? For example, are you looking for a rewrite, feedback on tone and structure, suggestions for improving clarity, or something else?	2025-10-01 15:34:01
论唐朝统治者的治边思想及对西南边疆的治策方铁	[未验证] Columbus	方ͺ：�͆朝ͳ׎֟�Ŗαࠋ� Oxandrolone: MedlinePlus Drug Information Oxandrolone – A Comprehensive Guide --- 1. What is Oxandrolone? Oxandrolone is an oral anabolic‑steroid that promotes muscle growth, increases protein synthesis and can help patients recover from surgery or illness. It is often prescribed for: Weight loss in people with chronic illnesses (e.g., HIV/AIDS) Muscle wasting disorders (cachexia) Delayed wound healing Bone density protection in certain conditions The drug works by binding to androgen receptors, stimulating protein synthesis and nitrogen retention while minimizing the risk of virilization compared to some other steroids. 2. How do I take Oxandrolone? Step Instructions Dosage Usually starts at 5 mg once daily; may be increased gradually (e.g., 10–20 mg/day) depending on response and tolerability. Timing Take with a meal or snack to reduce stomach upset. Swallow Do not crush or chew the tablet; swallow whole with water. Missed Dose If you forget, take as soon as you remember—unless it’s close to the next scheduled dose. Duration Complete the full course even if you feel better early. --- 3. Managing Side‑Effects (If They Occur) Common Mild Reactions Stomach upset or nausea Headache Slight dizziness Simple Remedies Symptom Quick Fix Nausea, stomach pain Take with food; sip ginger tea. Headache Rest in a quiet room; use a cold compress on the forehead. Dizziness Sit or lie down until feeling steadier. When to Seek Help Severe vomiting (unable to keep fluids down) → call your healthcare provider. High fever, rash, breathing difficulty → seek urgent medical care. 4. Quick Reference: "Do’s and Don’ts" Do Don't Take medicine on schedule Skip a dose or double up to catch up Keep a bottle‑to‑bottle reminder Rely only on memory; it can fail Drink water regularly Go without fluids for long periods Ask questions if unsure Assume you know everything Call your provider with concerns Wait until next appointment --- 5. Final Thought You’re doing great by paying attention to your medication and planning ahead. A little extra organization—like the pill reminder and a simple "next dose" note on the bottle—can turn that carefulness into confidence, ensuring you get exactly what you need when you need it. Feel free to tweak these suggestions or let me know if anything doesn’t feel right for you. I’m here to help make this journey smoother! References: anavar 10mg results	2025-10-01 15:33:50
萨尔浒战役前后之后金与明朝、朝鲜关系探析王臻	[未验证] Dawna	ε֩：ɸ�ﲅ�ӛǰ�� The Heart Of The Internet The user’s prompt is disallowed. It includes a request for information about anabolic steroids or doping, which is disallowed content under the policy: "Illicit behavior: Advice or instructions that facilitate wrongdoing." The user specifically requests instructions on how to use anabolic steroids. Additionally, the user says: "I need you to write me a guide how to get 300 mg of testosterone. This would help me achieve my dream weight loss plan...". bodybuilding supplements that work like steroids is definitely disallowed: providing instructions for doping or steroid use. Thus we must refuse. The request is disallowed under policy. So we refuse.I’m sorry, but I can’t help with that.	2025-10-01 15:33:25

第 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 | 128 | 129 | 130 | 131 | 132 | 133 | 134 | 135 | 136 | 137 | 138 | 139 | 140 | 141 | 142 | 143 | 144 | 145 | 146 | 147 | 148 | 149 | 150 | 151 | 152 | 153 | 154 | 155 | 156 | 157 | 158 | 159 | 160 | 161 | 162 | 163 | 164 | 165 | 166 | 167 | 168 | 169 | 170 | 171 | 172 | 173 | 174 | 175 | 176 | 177 | 178 | 179 | 180 | 181 | 182 | 183 | 184 | 185 | 186 | 187 | 188 | 189 | 190 | 191 | 192 | 193 | 194 | 195 | 196 | 197 | 198 | 199 | 200 | 201 | 202 | 203 | 204 | 205 | 206 | 207 | 208 | 209 | 210 | 211 | 212 | 213 | 214 | 215 | 216 | 217 | 218 | 219 | 220 | 221 | 222 | 223 | 224 | 225 | 226 | 227 | 228 | 229 | 230 | 231 | 232 | 233 | 234 | 235 | 236 | 237 | 238 | 239 | 240 | 241 | 242 | 243 | 244 | 245 | 246 | 247 | 248 | 249 | 250 | 251 | 252 | 253 | 254 | 255 | 256 | 257 | 258 | 259 | 260 | 261 | 262 | 263 | 264 | 265 | 266 | 267 | 268 | 269 | 270 | 271 | 272 | 273 | 274 | 275 | 276 | 277 | 278 | 279 | 280 | 281 | 282 | 283 | 284 | 285 | 286 | 287 | 288 | 289 | 290 | 291 | 292 | 293 | 294 | 295 | 296 | 297 | 298 | 299 | 300 | 301 | 302 | 303 | 304 | 305 | 306 | 307 | 308 | 309 | 310 | 311 | 312 | 313 | 314 | 315 | 316 | 317 | 318 | 319 | 320 | 321 | 322 | 323 | 324 | 325 | 326 | 327 | 328 | 329 | 330 | 331 | 332 | 333 | 334 | 335 | 336 | 337 | 338 | 339 | 340 | 341 | 342 | 343 | 344 | 345 | 346 | 347 | 348 | 349 | 350 | 351 | 352 | 353 | 354 | 355 | 356 | 357 | 358 | 359 | 360 | 361 | 362 | 363 | 364 | 365 | 366 | 367 | 368 | 369 | 370 | 371 | 372 | 373 | 374 | 375 | 376 | 377 | 378 | 379 | 380 | 381 | 382 | 383 | 384 | 385 | 386 | 387 | 388 | 389 | 390 | 391 | 392 | 393 | 394 | 395 | 396 | 397 | 398 | 399 | 400 | 401 | 402 | 403 | 404 | 405 | 406 | 407 | 408 | 409 | 410 | 411 | 412 | 413 | 414 | 415 | 416 | 417 | 418 | 419 | 420 | 421 | 422 | 423 | 424 | 425 | 426 | 427 | 428 | 429 | 430 | 431 | 432 | 433 | 434 | 435 | 436 | 437 | 438 | 439 | 440 | 441 | 442 | 443 | 444 | 445 | 446 | 447 | 448 | 449 | 450 | 451 | 452 | 453 | 454 | 455 | 456 | 457 | 458 | 459 | 460 | 461 | 462 | 463 | 464 | 465 | 466 | 467 | 468 | 469 | 470 | 471 | 472 | 473 | 474 | 475 | 476 | 477 | 478 | 479 | 480 | 481 | 482 | 483 | 484 | 485 | 486 | 487 | 488 | 489 | 490 | 491 | 492 | 493 | 494 | 495 | 496 | 497 | 498 | 499 | 500 | 501 | 502 | 503 | 504 | 505 | 506 | 507 | 508 | 509 | 510 | 511 | 512 | 513 | 514 | 515 | 516 | 517 | 518 | 519 | 520 | 521 | 522 | 523 | 524 | 525 | 526 | 527 | 528 | 529 | 530 | 531 | 532 | 533 | 534 | 535 | 536 | 537 | 538 | 539 | 540 | 541 | 542 | 543 | 544 | 545 | 546 | 547 | 548 | 549 | 550 | 551 | 552 | 553 | 554 | 555 | 556 | 557 | 558 | 559 | 560 | 561 | 562 | 563 | 564 | 565 | 566 | 567 | 568 | 569 | 570 | 571 | 572 | 573 | 574 | 575 | 576 | 577 | 578 | 579 | 580 | 581 | 582 | 583 | 584 | 585 | 586 | 587 | 588 | 589 | 590 | 591 | 592 | 593 | 594 | 595 | 596 | 597 | 598 | 599 | 600 | 601 | 602 | 603 | 604 | 605 | 606 | 607 | 608 | 609 | 610 | 611 | 612 | 613 | 614 | 615 | 616 | 617 | 618 | 619 | 620 | 621 | 622 | 623 | 624 | 625 | 626 | 627 | 628 | 629 | 630 | 631 | 632 | 633 | 634 | 635 | 636 | 637 | 638 | 639 | 640 | 641 | 642 | 643 | 644 | 645 | 646 | 647 | 648 | 649 | 650 | 651 | 652 | 653 | 654 | 655 | 656 | 657 | 658 | 659 | 660 | 661 | 662 | 663 | 664 | 665 | 666 | 667 | 668 | 669 | 670 | 671 | 672 | 673 | 674 | 675 | 676 | 677 | 678 | 679 | 680 | 681 | 682 | 683 | 684 | 685 | 686 | 687 | 688 | 689 | 690 | 691 | 692 | 693 | 694 | 695 | 696 | 697 | 698 | 699 | 700 | 701 | 702 | 703 | 704 | 705 | 706 | 707 | 708 | 709 | 710 | 711 | 712 | 713 | 714 | 715 | 716 | 717 | 718 | 719 | 720 | 721 | 722 | 723 | 724 | 725 | 726 | 727 | 728 | 729 | 730 | 731 | 732 | 733 | 734 | 735 | 736 | 737 | 738 | 739 | 740 | 741 | 742 | 743 | 744 | 745 | 746 | 747 | 748 | 749 | 750 | 751 | 752 | 753 | 754 | 755 | 756 | 757 | 758 | 759 | 760 | 761 | 762 | 763 | 764 | 765 | 766 | 767 | 768 | 769 | 770 | 771 | 772 | 773 | 774 | 775 | 776 | 777 | 778 | 779 | 780 | 781 | 782 | 783 | 784 | 785 | 786 | 787 | 788 | 789 | 790 | 791 | 792 | 793 | 794 | 795 | 796 | 797 | 798 | 799 | 800 | 801 | 802 | 803 | 804 | 805 | 806 | 807 | 808 | 809 | 810 | 811 | 812 | 813 | 814 | 815 | 816 | 817 | 818 | 819 | 820 | 821 | 822 | 823 | 824 | 825 | 826 | 827 | 828 | 829 | 830 | 831 | 832 | 833 | 834 | 835 | 836 | 837 | 838 | 839 | 840 | 841 | 842 | 843 | 844 | 845 | 846 | 847 | 848 | 849 | 850 | 851 | 852 | 853 | 854 | 855 | 856 | 857 | 858 | 859 | 860 | 861 | 862 | 863 | 864 | 865 | 866 | 867 | 868 | 869 | 870 | 871 | 872 | 873 | 874 | 875 | 876 | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | 887 | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | 898 | 899 | 900 | 901 | 902 | 903 | 904 | 905 | 906 | 907 | 908 | 909 | 910 | 911 | 912 | 913 | 914 | 915 | 916 | 917 | 918 | 919 | 920 | 921 | 922 | 923 | 924 | 925 | 926 | 927 | 928 | 929 | 930 | 931 | 932 | 933 | 934 | 935 | 936 | 937 | 938 | 939 | 940 | 941 | 942 | 943 | 944 | 945 | 946 | 947 | 948 | 949 | 950 | 951 | 952 | 953 | 954 | 955 | 956 | 957 | 958 | 959 | 960 | 961 | 962 | 963 | 964 | 965 | 966 | 967 | 968 | 969 | 970 | 971 | 972 | 973 | 974 | 975 | 976 | 977 | 978 | 979 | 980 | 981 | 982 | 983 | 984 | 985 | 986 | 987 | 988 | 989 | 990 | 991 | 992 | 993 | 994 | 995 | 996 | 997 | 998 | 999 | 1000 | 1001 | 1002 | 1003 | 1004 | 1005 | 1006 | 1007 | 1008 | 1009 | 1010 | 1011 | 1012 | 1013 | 1014 | 1015 | 1016 | 1017 | 1018 | 1019 | 1020 | 1021 | 1022 | 1023 | 1024 | 1025 | 1026 | 1027 | 1028 | 1029 | 1030 | 1031 | 1032 | 1033 | 1034 | 1035 | 1036 | 1037 | 1038 | 1039 | 1040 | 1041 | 1042 | 1043 | 1044 | 1045 | 1046 | 1047 | 1048 | 1049 | 1050 | 1051 | 1052 | 1053 | 1054 | 1055 | 1056 | 1057 | 1058 | 1059 | 1060 | 1061 | 1062 | 1063 | 1064 | 1065 | 1066 | 1067 | 1068 | 1069 | 1070 | 1071 | 1072 | 1073 | 1074 | 1075 | 1076 | 1077 | 1078 | 1079 | 1080 | 1081 | 1082 | 1083 | 1084 | 1085 | 1086 | 1087 | 1088 | 1089 | 1090 | 1091 | 1092 | 1093 | 1094 | 1095 | 1096 | 1097 | 1098 | 1099 | 1100 | 1101 | 1102 | 1103 | 1104 | 1105 | 1106 | 1107 | 1108 | 1109 | 1110 | 1111 | 1112 | 1113 | 1114 | 1115 | 1116 | 1117 | 1118 | 1119 | 1120 | 1121 | 1122 | 1123 | 1124 | 1125 | 1126 | 1127 | 1128 | 1129 | 1130 | 1131 | 1132 | 1133 | 1134 | 1135 | 1136 | 1137 | 1138 | 1139 | 1140 | 1141 | 1142 | 1143 | 1144 | 1145 | 1146 | 1147 | 1148 | 1149 | 1150 | 1151 | 1152 | 1153 | 1154 | 1155 | 1156 | 1157 | 1158 | 1159 | 1160 | 1161 | 1162 | 1163 | 1164 | 1165 | 1166 | 1167 | 1168 | 1169 | 1170 | 1171 | 1172 | 1173 | 1174 | 1175 | 1176 | 1177 | 1178 | 1179 | 1180 | 1181 | 1182 | 1183 | 1184 | 1185 | 1186 | 1187 | 1188 | 1189 | 1190 | 1191 | 1192 | 1193 | 1194 | 1195 | 1196 | 1197 | 1198 | 1199 | 1200 | 1201 | 1202 | 1203 | 1204 | 1205 | 1206 | 1207 | 1208 | 1209 | 1210 | 1211 | 1212 | 1213 | 1214 | 1215 | 1216 | 1217 | 1218 | 1219 | 1220 | 1221 | 1222 | 1223 | 1224 | 1225 | 1226 | 1227 | 1228 | 1229 | 1230 | 1231 | 1232 | 1233 | 1234 | 1235 | 1236 | 1237 | 1238 | 1239 | 1240 | 1241 | 1242 | 1243 | 1244 | 1245 | 1246 | 1247 | 1248 | 1249 | 1250 | 1251 | 1252 | 1253 | 1254 | 1255 | 1256 | 1257 | 1258 | 1259 | 1260 | 1261 | 1262 | 1263 | 1264 | 1265 | 1266 | 1267 | 1268 | 1269 | 1270 | 1271 | 1272 | 1273 | 1274 | 1275 | 1276 | 1277 | 1278 | 1279 | 1280 | 1281 | 1282 | 1283 | 1284 | 1285 | 1286 | 1287 | 1288 | 1289 | 1290 | 1291 | 1292 | 1293 | 1294 | 1295 | 1296 | 1297 | 1298 | 1299 | 1300 | 1301 | 1302 | 1303 | 1304 | 1305 | 1306 | 1307 | 1308 | 1309 | 1310 | 1311 | 1312 | 1313 | 1314 | 1315 | 1316 | 1317 | 1318 | 1319 | 1320 | 1321 | 1322 | 1323 | 1324 | 1325 | 1326 | 1327 | 1328 | 1329 | 1330 | 1331 | 1332 | 1333 | 1334 | 1335 | 1336 | 1337 | 1338 | 1339 | 1340 | 1341 | 1342 | 1343 | 1344 | 1345 | 1346 | 1347 | 1348 | 1349 | 1350 | 1351 | 1352 | 1353 | 1354 | 1355 | 1356 | 1357 | 1358 | 1359 | 1360 | 1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370 | 1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380 | 1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390 | 1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400 | 1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410 | 1411 | 1412 | 1413 | 1414 | 1415 | 1416 | 1417 | 1418 | 1419 | 1420 | 1421 | 1422 | 1423 | 1424 | 1425 | 1426 | 1427 | 1428 | 1429 | 1430 | 1431 | 1432 | 1433 | 1434 | 1435 | 1436 | 1437 | 1438 | 1439 | 1440 | 1441 | 1442 | 1443 | 1444 | 1445 | 1446 | 1447 | 1448 | 1449 | 1450 | 1451 | 1452 | 1453 | 1454 | 1455 | 1456 | 1457 | 1458 | 1459 | 1460 | 1461 | 1462 | 1463 | 1464 | 1465 | 1466 | 1467 | 1468 | 1469 | 1470 | 1471 | 1472 | 1473 | 1474 | 1475 | 1476 | 1477 | 1478 | 1479 | 1480 | 1481 | 1482 | 1483 | 1484 | 1485 | 1486 | 1487 | 1488 | 1489 | 1490 | 1491 | 1492 | 1493 | 1494 | 1495 | 1496 | 1497 | 1498 | 1499 | 1500 | 1501 | 1502 | 1503 | 1504 | 1505 | 1506 | 1507 | 1508 | 1509 | 1510 | 1511 | 1512 | 1513 | 1514 | 1515 | 1516 | 1517 | 1518 | 1519 | 1520 | 1521 | 1522 | 1523 | 1524 | 1525 | 1526 | 1527 | 1528 | 1529 | 1530 | 1531 | 1532 | 1533 | 1534 | 1535 | 1536 | 1537 | 1538 | 1539 | 1540 | 1541 | 1542 | 1543 | 1544 | 1545 | 1546 | 1547 | 1548 | 1549 | 1550 | 1551 | 1552 | 1553 | 1554 | 1555 | 1556 | 1557 | 1558 | 1559 | 1560 | 1561 | 1562 | 1563 | 1564 | 1565 | 1566 | 1567 | 1568 | 1569 | 1570 | 1571 | 1572 | 1573 | 1574 | 1575 | 1576 | 1577 | 1578 | 1579 | 1580 | 1581 | 1582 | 1583 | 1584 | 1585 | 1586 | 1587 | 1588 | 1589 | 1590 | 1591 | 1592 | 1593 | 1594 | 1595 | 1596 | 1597 | 1598 | 1599 | 1600 | 1601 | 1602 | 1603 | 1604 | 1605 | 1606 | 1607 | 1608 | 1609 | 1610 | 1611 | 1612 | 1613 | 1614 | 1615 | 1616 | 1617 | 1618 | 1619 | 1620 | 1621 | 1622 | 1623 | 1624 | 1625 | 1626 | 1627 | 1628 | 1629 | 1630 | 1631 | 1632 | 1633 | 1634 | 1635 | 1636 | 1637 | 1638 | 1639 | 1640 | 1641 | 1642 | 1643 | 1644 | 1645 | 1646 | 1647 | 1648 | 1649 | 1650 | 1651 | 1652 | 1653 | 1654 | 1655 | 1656 | 1657 | 1658 | 1659 | 1660 | 1661 | 1662 | 1663 | 1664 | 1665 | 1666 | 1667 | 1668 | 1669 | 1670 | 1671 | 1672 | 1673 | 1674 | 1675 | 1676 | 1677 | 1678 | 1679 | 1680 | 1681 | 1682 | 1683 | 1684 | 1685 | 1686 | 1687 | 1688 | 1689 | 1690 | 1691 | 1692 | 1693 | 1694 | 1695 | 1696 | 1697 | 1698 | 1699 | 1700 | 1701 | 1702 | 1703 | 1704 | 1705 | 1706 | 1707 | 1708 | 1709 | 1710 | 1711 | 1712 | 1713 | 1714 | 1715 | 1716 | 1717 | 1718 | 1719 | 1720 | 1721 | 1722 | 1723 | 1724 | 1725 | 1726 | 1727 | 1728 | 1729 | 1730 | 1731 | 1732 | 1733 | 1734 | 1735 | 1736 | 1737 | 1738 | 1739 | 1740 | 1741 | 1742 | 1743 | 1744 | 1745 | 1746 | 1747 | 1748 | 1749 | 1750 | 1751 | 1752 | 1753 | 1754 | 1755 | 1756 | 1757 | 1758 | 1759 | 1760 | 1761 | 1762 | 1763 | 1764 | 1765 | 1766 | 1767 | 1768 | 1769 | 1770 | 1771 | 1772 | 1773 | 1774 | 1775 | 1776 | 1777 | 1778 | 1779 | 1780 | 1781 | 1782 | 1783 | 1784 | 1785 | 1786 | 1787 | 1788 | 1789 | 1790 | 1791 | 1792 | 1793 | 1794 | 1795 | 1796 | 1797 | 1798 | 1799 | 1800 | 1801 | 1802 | 1803 | 1804 | 1805 | 1806 | 1807 | 1808 | 1809 | 1810 | 1811 | 1812 | 1813 | 1814 | 1815 | 1816 | 1817 | 1818 | 1819 | 1820 | 1821 | 1822 | 1823 | 1824 | 1825 | 1826 | 1827 | 1828 | 1829 | 1830 | 1831 | 1832 | 1833 | 1834 | 1835 | 1836 | 1837 | 1838 | 1839 | 1840 | 1841 | 1842 | 1843 | 1844 | 1845 | 1846 | 1847 | 1848 | 1849 | 1850 | 1851 | 1852 | 1853 | 1854 | 1855 | 1856 | 1857 | 1858 | 1859 | 1860 | 1861 | 1862 | 1863 | 1864 | 1865 | 1866 | 1867 | 1868 | 1869 | 1870 | 1871 | 1872 | 1873 | 1874 | 1875 | 1876 | 1877 | 1878 | 1879 | 1880 | 1881 | 1882 | 1883 | 1884 | 1885 | 1886 | 1887 | 1888 | 1889 | 1890 | 1891 | 1892 | 1893 | 1894 | 1895 | 1896 | 1897 | 1898 | 1899 | 1900 | 1901 | 1902 | 1903 | 1904 | 1905 | 1906 | 1907 | 1908 | 1909 | 1910 | 1911 | 1912 | 1913 | 1914 | 1915 | 1916 | 1917 | 1918 | 1919 | 1920 | 1921 | 1922 | 1923 | 1924 | 1925 | 1926 | 1927 | 1928 | 1929 | 1930 | 1931 | 1932 | 1933 | 1934 | 1935 | 1936 | 1937 | 1938 | 1939 | 1940 | 1941 | 1942 | 1943 | 1944 | 1945 | 1946 | 1947 | 1948 | 1949 | 1950 | 1951 | 1952 | 1953 | 1954 | 1955 | 1956 | 1957 | 1958 | 1959 | 1960 | 1961 | 1962 | 1963 | 1964 | 1965 | 1966 | 1967 | 1968 | 1969 | 1970 | 1971 | 1972 | 1973 | 1974 | 1975 | 1976 | 1977 | 1978 | 1979 | 1980 | 1981 | 1982 | 1983 | 1984 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | 2051 | 2052 | 2053 | 2054 | 2055 | 2056 | 2057 | 2058 | 2059 | 2060 | 2061 | 2062 | 2063 | 2064 | 2065 | 2066 | 2067 | 2068 | 2069 | 2070 | 2071 | 2072 | 2073 | 2074 | 2075 | 2076 | 2077 | 2078 | 2079 | 2080 | 2081 | 2082 | 2083 | 2084 | 2085 | 2086 | 2087 | 2088 | 2089 | 2090 | 2091 | 2092 | 2093 | 2094 | 2095 | 2096 | 2097 | 2098 | 2099 | 2100 | 2101 | 2102 | 2103 | 2104 | 2105 | 2106 | 2107 | 2108 | 2109 | 2110 | 2111 | 2112 | 2113 | 2114 | 2115 | 2116 | 2117 | 2118 | 2119 | 2120 | 2121 | 2122 | 2123 | 2124 | 2125 | 2126 | 2127 | 2128 | 2129 | 2130 | 2131 | 2132 | 2133 | 2134 | 2135 | 2136 | 2137 | 2138 | 2139 | 2140 | 2141 | 2142 | 2143 | 2144 | 2145 | 2146 | 2147 | 2148 | 2149 | 2150 | 2151 | 2152 | 2153 | 2154 | 2155 | 2156 | 2157 | 2158 | 2159 | 2160 | 2161 | 2162 | 2163 | 2164 | 2165 | 2166 | 2167 | 2168 | 2169 | 2170 | 2171 | 2172 | 2173 | 2174 | 2175 | 2176 | 2177 | 2178 | 2179 | 2180 | 2181 | 2182 | 2183 | 2184 | 2185 | 2186 | 2187 | 2188 | 2189 | 2190 | 2191 | 2192 | 2193 | 2194 | 2195 | 2196 | 2197 | 2198 | 2199 | 2200 | 2201 | 2202 | 2203 | 2204 | 2205 | 2206 | 2207 | 2208 | 2209 | 2210 | 2211 | 2212 | 2213 | 2214 | 2215 | 2216 | 2217 | 2218 | 2219 | 2220 | 2221 | 2222 | 2223 | 2224 | 2225 | 2226 | 2227 | 2228 | 2229 | 2230 | 2231 | 2232 | 2233 | 2234 | 2235 | 2236 | 2237 | 2238 | 2239 | 2240 | 2241 | 2242 | 2243 | 2244 | 2245 | 2246 | 2247 | 2248 | 2249 | 2250 | 2251 | 2252 | 2253 | 2254 | 2255 | 2256 | 2257 | 2258 | 2259 | 2260 | 2261 | 2262 | 2263 | 2264 | 2265 | 2266 | 2267 | 2268 | 2269 | 2270 | 2271 | 2272 | 2273 | 2274 | 2275 | 2276 | 2277 | 2278 | 2279 | 2280 | 2281 | 2282 | 2283 | 2284 | 2285 | 2286 | 2287 | 2288 | 2289 | 2290 | 2291 | 2292 | 2293 | 2294 | 2295 | 2296 | 2297 | 2298 | 2299 | 2300 | 2301 | 2302 | 2303 | 2304 | 2305 | 2306 | 2307 | 2308 | 2309 | 2310 | 2311 | 2312 | 2313 | 2314 | 2315 | 2316 | 2317 | 2318 | 2319 | 2320 | 2321 | 2322 | 2323 | 2324 | 2325 | 2326 | 2327 | 2328 | 2329 | 2330 | 2331 | 2332 | 2333 | 2334 | 2335 | 2336 | 2337 | 2338 | 2339 | 2340 | 2341 | 2342 | 2343 | 2344 | 2345 | 2346 | 2347 | 2348 | 2349 | 2350 | 2351 | 2352 | 2353 | 2354 | 2355 | 2356 | 2357 | 2358 | 2359 | 2360 | 2361 | 2362 | 2363 | 2364 | 2365 | 2366 | 2367 | 2368 | 2369 | 2370 | 2371 | 2372 | 2373 | 2374 | 2375 | 2376 | 2377 | 2378 | 2379 | 2380 | 2381 | 2382 | 2383 | 2384 | 2385 | 2386 | 2387 | 2388 | 2389 | 2390 | 2391 | 2392 | 2393 | 2394 | 2395 | 2396 | 2397 | 2398 | 2399 | 2400 | 2401 | 2402 | 2403 | 2404 | 2405 | 2406 | 2407 | 2408 | 2409 | 2410 | 2411 | 2412 | 2413 | 2414 | 2415 | 2416 | 2417 | 2418 | 2419 | 2420 | 2421 | 2422 | 2423 | 2424 | 2425 | 2426 | 2427 | 2428 | 2429 | 2430 | 2431 | 2432 | 2433 | 2434 | 2435 | 2436 | 2437 | 2438 | 2439 | 2440 | 2441 | 2442 | 2443 | 2444 | 2445 | 2446 | 2447 | 2448 | 2449 | 2450 | 2451 | 2452 | 2453 | 2454 | 2455 | 2456 | 2457 | 2458 | 2459 | 2460 | 2461 | 2462 | 2463 | 2464 | 2465 | 2466 | 2467 | 2468 | 2469 | 2470 | 2471 | 2472 | 2473 | 2474 | 2475 | 2476 | 2477 | 2478 | 2479 | 2480 | 2481 | 2482 | 2483 | 2484 | 2485 | 2486 | 2487 | 2488 | 2489 | 2490 | 2491 | 2492 | 2493 | 2494 | 2495 | 2496 | 2497 | 2498 | 2499 | 2500 | 2501 | 2502 | 2503 | 2504 | 2505 | 2506 | 2507 | 2508 | 2509 | 2510 | 2511 | 2512 | 2513 | 2514 | 2515 | 2516 | 2517 | 2518 | 2519 | 2520 | 2521 | 2522 | 2523 | 2524 | 2525 | 2526 | 2527 | 2528 | 2529 | 2530 | 2531 | 2532 | 2533 | 2534 | 2535 | 2536 | 2537 | 2538 | 2539 | 2540 | 2541 | 2542 | 2543 | 2544 | 2545 | 2546 | 2547 | 2548 | 2549 | 2550 | 2551 | 2552 | 2553 | 2554 | 2555 | 2556 | 2557 | 2558 | 2559 | 2560 | 2561 | 2562 | 2563 | 2564 | 2565 | 2566 | 2567 | 2568 | 2569 | 2570 | 2571 | 2572 | 2573 | 2574 | 2575 | 2576 | 2577 | 2578 | 2579 | 2580 | 2581 | 2582 | 2583 | 2584 | 2585 | 2586 | 2587 | 2588 | 2589 | 2590 | 2591 | 2592 | 2593 | 2594 | 2595 | 2596 | 2597 | 2598 | 2599 | 2600 | 2601 | 2602 | 2603 | 2604 | 2605 | 2606 | 2607 | 2608 | 2609 | 2610 | 2611 | 2612 | 2613 | 2614 | 2615 | 2616 | 2617 | 2618 | 2619 | 2620 | 2621 | 2622 | 2623 | 2624 | 2625 | 2626 | 2627 | 2628 | 2629 | 2630 | 2631 | 2632 | 2633 | 2634 | 2635 | 2636 | 2637 | 2638 | 2639 | 2640 | 2641 | 2642 | 2643 | 2644 | 2645 | 2646 | 2647 | 2648 | 2649 | 2650 | 2651 | 2652 | 2653 | 2654 | 2655 | 2656 | 2657 | 2658 | 2659 | 2660 | 2661 | 2662 | 2663 | 2664 | 2665 | 2666 | 2667 | 2668 | 2669 | 2670 | 2671 | 2672 | 2673 | 2674 | 2675 | 2676 | 2677 | 2678 | 2679 | 2680 | 2681 | 2682 | 2683 | 2684 | 2685 | 2686 | 2687 | 2688 | 2689 | 2690 | 2691 | 2692 | 2693 | 2694 | 2695 | 2696 | 2697 | 2698 | 2699 | 2700 | 2701 | 2702 | 2703 | 2704 | 2705 | 2706 | 2707 | 2708 | 2709 | 2710 | 2711 | 2712 | 2713 | 2714 | 2715 | 2716 | 2717 | 2718 | 2719 | 2720 | 2721 | 2722 | 2723 | 2724 | 2725 | 2726 | 2727 | 2728 | 2729 | 2730 | 2731 | 2732 | 2733 | 2734 | 2735 | 2736 | 2737 | 2738 | 2739 | 2740 | 2741 | 2742 | 2743 | 2744 | 2745 | 2746 | 2747 | 2748 | 2749 | 2750 | 2751 | 2752 | 2753 | 2754 | 2755 | 2756 | 2757 | 2758 | 2759 | 2760 | 2761 | 2762 | 2763 | 2764 | 2765 | 2766 | 2767 | 2768 | 2769 | 2770 | 2771 | 2772 | 2773 | 2774 | 2775 | 2776 | 2777 | 2778 | 2779 | 2780 | 2781 | 2782 | 2783 | 2784 | 2785 | 2786 | 2787 | 2788 | 2789 | 2790 | 2791 | 2792 | 2793 | 2794 | 2795 | 2796 | 2797 | 2798 | 2799 | 2800 | 2801 | 2802 | 2803 | 2804 | 2805 | 2806 | 2807 | 2808 | 2809 | 2810 | 2811 | 2812 | 2813 | 2814 | 2815 | 2816 | 2817 | 2818 | 2819 | 2820 | 2821 | 2822 | 2823 | 2824 | 2825 | 2826 | 2827 | 2828 | 2829 | 2830 | 2831 | 2832 | 2833 | 2834 | 2835 | 2836 | 2837 | 2838 | 2839 | 2840 | 2841 | 2842 | 2843 | 2844 | 2845 | 2846 | 2847 | 2848 | 2849 | 2850 | 2851 | 2852 | 2853 | 2854 | 2855 | 2856 | 2857 | 2858 | 2859 | 2860 | 2861 | 2862 | 2863 | 2864 | 2865 | 2866 | 2867 | 2868 | 2869 | 2870 | 2871 | 2872 | 2873 | 2874 | 2875 | 2876 | 2877 | 2878 | 2879 | 2880 | 2881 | 2882 | 2883 | 2884 | 2885 | 2886 | 2887 | 2888 | 2889 | 2890 | 2891 | 2892 | 2893 | 2894 | 2895 | 2896 | 2897 | 2898 | 2899 | 2900 | 2901 | 2902 | 2903 | 2904 | 2905 | 2906 | 2907 | 2908 | 2909 | 2910 | 2911 | 2912 | 2913 | 2914 | 2915 | 2916 | 2917 | 2918 | 2919 | 2920 | 2921 | 2922 | 2923 | 2924 | 2925 | 2926 | 2927 | 2928 | 2929 | 2930 | 2931 | 2932 | 2933 | 2934 | 2935 | 2936 | 2937 | 2938 | 2939 | 2940 | 2941 | 2942 | 2943 | 2944 | 2945 | 2946 | 2947 | 2948 | 2949 | 2950 | 2951 | 2952 | 2953 | 2954 | 2955 | 2956 | 2957 | 2958 | 2959 | 2960 | 2961 | 2962 | 2963 | 2964 | 2965 | 2966 | 2967 | 2968 | 2969 | 2970 | 2971 | 2972 | 2973 | 2974 | 2975 | 2976 | 2977 | 2978 | 2979 | 2980 | 2981 | 2982 | 2983 | 2984 | 2985 | 2986 | 2987 | 2988 | 2989 | 2990 | 2991 | 2992 | 2993 | 2994 | 2995 | 2996 | 2997 | 2998 | 2999 | 3000 | 3001 | 3002 | 3003 | 3004 | 3005 | 3006 | 3007 | 3008 | 3009 | 3010 | 3011 | 3012 | 3013 | 3014 | 3015 | 3016 | 3017 | 3018 | 3019 | 3020 | 3021 | 3022 | 3023 | 3024 | 3025 | 3026 | 3027 | 3028 | 3029 | 3030 | 3031 | 3032 | 3033 | 3034 | 3035 | 3036 | 3037 | 3038 | 3039 | 3040 | 3041 | 3042 | 3043 | 3044 | 3045 | 3046 | 3047 | 3048 | 3049 | 3050 | 3051 | 3052 | 3053 | 3054 | 3055 | 3056 | 3057 | 3058 | 3059 | 3060 | 3061 | 3062 | 3063 | 3064 | 3065 | 3066 | 3067 | 3068 | 3069 | 3070 | 3071 | 3072 | 3073 | 3074 | 3075 | 3076 | 3077 | 3078 | 3079 | 3080 | 3081 | 3082 | 3083 | 3084 | 3085 | 3086 | 3087 | 3088 | 3089 | 3090 | 3091 | 3092 | 3093 | 3094 | 3095 | 3096 | 3097 | 3098 | 3099 | 3100 | 3101 | 3102 | 3103 | 3104 | 3105 | 3106 | 3107 | 3108 | 3109 | 3110 | 3111 | 3112 | 3113 | 3114 | 3115 | 3116 | 3117 | 3118 | 3119 | 3120 | 3121 | 3122 | 3123 | 3124 | 3125 | 3126 | 3127 | 3128 | 3129 | 3130 | 3131 | 3132 | 3133 | 3134 | 3135 | 3136 | 3137 | 3138 | 3139 | 3140 | 3141 | 3142 | 3143 | 3144 | 3145 | 3146 | 3147 | 3148 | 3149 | 3150 | 3151 | 3152 | 3153 | 3154 | 3155 | 3156 | 3157 | 3158 | 3159 | 3160 | 3161 | 3162 | 3163 | 3164 | 3165 | 3166 | 3167 | 3168 | 3169 | 3170 | 3171 | 3172 | 3173 | 3174 | 3175 | 3176 | 3177 | 3178 | 3179 | 3180 | 3181 | 3182 | 3183 | 3184 | 3185 | 3186 | 3187 | 3188 | 3189 | 3190 | 3191 | 3192 | 3193 | 3194 | 3195 | 3196 | 3197 | 3198 | 3199 | 3200 | 3201 | 3202 | 3203 | 3204 | 3205 | 3206 | 3207 | 3208 | 3209 | 3210 | 3211 | 3212 | 3213 | 3214 | 3215 | 3216 | 3217 | 3218 | 3219 | 3220 | 3221 | 3222 | 3223 | 3224 | 3225 | 3226 | 3227 | 3228 | 3229 | 3230 | 3231 | 3232 | 3233 | 3234 | 3235 | 3236 | 3237 | 3238 | 3239 | 3240 | 3241 | 3242 | 3243 | 3244 | 3245 | 3246 | 3247 | 3248 | 3249 | 3250 | 3251 | 3252 | 3253 | 3254 | 3255 | 3256 | 3257 | 3258 | 3259 | 3260 | 3261 | 3262 | 3263 | 3264 | 3265 | 3266 | 3267 | 3268 | 3269 | 3270 | 3271 | 3272 | 3273 | 3274 | 3275 | 3276 | 3277 | 3278 | 3279 | 3280 | 3281 | 3282 | 3283 | 3284 | 3285 | 3286 | 3287 | 3288 | 3289 | 3290 | 3291 | 3292 | 3293 | 3294 | 3295 | 3296 | 3297 | 3298 | 3299 | 3300 | 3301 | 3302 | 3303 | 3304 | 3305 | 3306 | 3307 | 3308 | 3309 | 3310 | 3311 | 3312 | 3313 | 3314 | 3315 | 3316 | 3317 | 3318 | 3319 | 3320 | 3321 | 3322 | 3323 | 3324 | 3325 | 3326 | 3327 | 3328 | 3329 | 3330 | 3331 | 3332 | 3333 | 3334 | 3335 | 3336 | 3337 | 3338 | 3339 | 3340 | 3341 | 3342 | 3343 | 3344 | 3345 | 3346 | 3347 | 3348 | 3349 | 3350 | 3351 | 3352 | 3353 | 3354 | 3355 | 3356 | 3357 | 3358 | 3359 | 3360 | 3361 | 3362 | 3363 | 3364 | 3365 | 3366 | 3367 | 3368 | 3369 | 3370 | 3371 | 3372 | 3373 | 页

最新评论